Al M - Search Results

1

Research Costs Investigated: A Study Into the Budgets of Dutch Publicly Funded Drug-Related Research.

van Asselt T, Ramaekers B, Corro Ramos I, Joore M, Al M, Lesman-Leegte I, Postma M, Vemer P, Feenstra T. van Asselt T, et al. Among authors: al m. Pharmacoeconomics. 2018 Jan;36(1):105-113. doi: 10.1007/s40273-017-0572-7. Pharmacoeconomics. 2018. PMID: 28933003 Free PMC article.

2

The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis.

Al MJ, Michel BC, Rutten FF. Al MJ, et al. Pharmacoeconomics. 1996 Aug;10(2):141-51. doi: 10.2165/00019053-199610020-00006. Pharmacoeconomics. 1996. PMID: 10163417 Clinical Trial.

3

Methods to analyse cost data of patients who withdraw in a clinical trial setting.

Oostenbrink JB, Al MJ, Rutten-van Mölken MP. Oostenbrink JB, et al. Among authors: al mj. Pharmacoeconomics. 2003;21(15):1103-12. doi: 10.2165/00019053-200321150-00004. Pharmacoeconomics. 2003. PMID: 14596629 Clinical Trial.

4

Decision makers' views on health care objectives and budget constraints: results from a pilot study.

Al MJ, Feenstra T, Brouwer WB. Al MJ, et al. Health Policy. 2004 Oct;70(1):33-48. doi: 10.1016/j.healthpol.2004.01.009. Health Policy. 2004. PMID: 15312708

5

Portfolio theory and cost-effectiveness analysis: a further discussion.

Sendi P, Al MJ, Rutten FF. Sendi P, et al. Value Health. 2004 Sep-Oct;7(5):595-601. doi: 10.1111/j.1524-4733.2004.75010.x. Value Health. 2004. PMID: 15367254 Free article.

6

Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty.

Al MJ, Feenstra TL, Hout BA. Al MJ, et al. Health Econ. 2005 Jul;14(7):655-67. doi: 10.1002/hec.973. Health Econ. 2005. PMID: 15678518

7

Costs and effects of various analgesic treatments for patients with rheumatoid arthritis and osteoarthritis in the Netherlands.

Al MJ, Maniadakis N, Grijseels EW, Janssen M. Al MJ, et al. Value Health. 2008 Jul-Aug;11(4):589-99. doi: 10.1111/j.1524-4733.2007.00303.x. Epub 2008 Jan 8. Value Health. 2008. PMID: 18194404 Free article.

8

Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional research.

Oostenbrink JB, Al MJ, Oppe M, Rutten-van Mölken MP. Oostenbrink JB, et al. Among authors: al mj. Value Health. 2008 Dec;11(7):1070-80. doi: 10.1111/j.1524-4733.2008.00389.x. Value Health. 2008. PMID: 19602213 Free article.

9

Comparing methods of data synthesis: re-estimating parameters of an existing probabilistic cost-effectiveness model.

Oppe M, Al M, Rutten-van Mölken M. Oppe M, et al. Among authors: al m. Pharmacoeconomics. 2011 Mar;29(3):239-50. doi: 10.2165/11539870-000000000-00000. Pharmacoeconomics. 2011. PMID: 21142288

10

Association between lung function and exacerbation frequency in patients with COPD.

Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Mölken MR. Hoogendoorn M, et al. Among authors: al m. Int J Chron Obstruct Pulmon Dis. 2010 Dec 9;5:435-44. doi: 10.2147/COPD.S13826. Int J Chron Obstruct Pulmon Dis. 2010. PMID: 21191438 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

167 results

Search Page

Filters